Genolier Swiss Medical Network (GSMN): New CFO and new composition of the Senior Management

Genolier Swiss Medical Network (GSMN)  / Key word(s): Miscellaneous/Miscellaneous

29.04.2011 07:25

Release of an ad hoc announcement pursuant to Art. 72 KR

Genolier Swiss Medical Network announces the appointment of Ayhan Güzelgün
as Chief Financial Officer with effect from 1 August 2011 and Guy Reynard
as Chief Sales Officer with effect from 1 May 2011. The Senior Management
of the Group currently consists of Antoine Hubert, Managing Director, Beat
Röthlisberger, Chief Executive Officer (CEO), Ayhan Güzelgün, Chief
Financial Officer (CFO), Valérie Dubois-Héquet, Chief Operational Officer
(COO) and Guy Reynard, Chief Sales Officer (CSO).

Genolier Swiss Medical Network SA (GSMN) is the second largest network of
private clinics in Switzerland. Its growth strategy focuses on the creation
of a national network through the acquisition of clinics and the
restructuring of their operations. GSMN's main aim is to offer first class
hospital care to Swiss and foreign patients. The distinctive features of
GSMN include its high quality services, its brand value, a pleasant working
environment and an experienced management team with an entrepreneurial
approach. GSMN currently operates six private establishments in Switzerland
(Clinique de Genolier, Clinique de Montchoisi, Clinique Valmont, Centre
médico-chirurgical des Eaux-Vives and Privatklinik Bethanien), with more
than 560 practising physicians and 900 employees. The Group is listed on
the Domestic Standard of the SIX Swiss Exchange (GSMN:SW).

GSMN SA Press Service  
Séverine Van der Schueren 
Secretary General
Tel. 022 366 99 87

29.04.2011 News transmitted by EquityStory AG. 
The issuer is responsible for the contents of the release.

EquityStory publishes regulatory releases, media releases on the capital 
market and press releases.
The EquityStory Group distributes authentic and real-time financial news 
for over 1'300 listed companies. 
The Swiss news archive can be found at

This website uses cookies.
Please see our Privacy Guidelines for further details.